PTPN11 and cancer: Consequently, we postulated that SHP2-AIs with pronounced off-target autophagy inhibition (e.g., SHP099 and IACS-13909) may be more effective than more selective SHP2 inhibitors (e.g., TNO155 and RMC-4550) in the treatment of cancers addicted to autophagy.